Trial intelligence / Profile preview

Pedyphar vs Panthenol for Diabetic Foot Ulcers

NCT02379468Phase 3Completed

Sponsor
European Egyptian Pharmaceutical Industries
Start
Apr 2013
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of royal jelly + panthenol in diabetic foot ulcer (DFU), sponsored by European Egyptian Pharmaceutical Industries. Started Apr 2013; status: completed.

02

Drugs

royal jelly + panthenol
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT02379468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02379468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call